tirzepatide shortage FDA says is over after taking a second look Lilly Threatens Obesity Drug Copycat

Many private insurers limit coverage for injectable GLP-1s because of cost

Rotate between at least 3 to 4 sites to prevent lipodystrophy and scar tissue buildup that can slow absorption over time

Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."

the GSH group up-regulated 48 differential metabolites and down-regulated 68 differential metabolites relative to the NC group